Laurus Labs Limited has informed the Exchange regarding a press release dated January 21, 2022, titled "Laurus Labs signs an agreement with MPP (Medicine Patient Pool) to manufacture Molnupiravir, oral COVID-19 antiviral medication".
Press Release Jan 21 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Laurus Labs
- Press Release Nov 19 2021
- Press Release Oct 28 2021
- Press Release Sep 14 2021
- Press Release Jul 29 2021
- Press Release Jul 02 2021
Later from Laurus Labs
- Press Release Jan 27 2022
- Press Release Apr 28 2022
- Press Release Jul 27 2022
- Press Release Oct 21 2022
- Press Release Jan 30 2023
Follow Laurus Labs into a list and get an email when it puts out news.
Follow Laurus Labs